• 2 days ago
(Adnkronos) - “Non posso perdere l'opportunità di dire che abbiamo realmente un problema per il nostro futuro qui in Italia. Noi parliamo di sostenibilità, ma non c'è sostenibilità se non ci sono bambini per sostenere il futuro. In Italia ogni anno c'è una riduzione del numero dei nuovi nati: nel 2023 sono nati 400 bambini in meno, 3,4% in meno rispetto il 2022 e il 25% rispetto a dieci anni fa. È un tema economico, ma non solo, c'è anche una mancanza di educazione”. Così Ramon Palou de Comasema Sureda, amministratore delegato di Merck Italia, a margine dell’evento ‘Essere genitori oggi, tra scienza e welfare’, il nuovo appuntamento di Adnkronos Q&A organizzato in collaborazione con Demografica e Merck, con il sostegno di Medical service consulting, Ivi, Nuova collaborazione associazione nazionale datori di lavoro domestico e WindTre. L’incontro ha l’obiettivo di accendere i riflettori sul sostegno alla genitorialità attraverso alcune direttrici fondamentali: la politica economica, l’educazione e la prevenzione per favorire la fertilità, le tecniche per superare l’infertilità e l’implementazione di un welfare aziendale orientato a favorire scelte di vita coerenti con un incremento della natalità.

Category

🗞
News
Transcript
00:00What are your plans for the future of Italy?
00:04First, I can't miss the opportunity to reinforce that we really have a problem for our future here in Italy.
00:11We talk about sustainability. There is no sustainability when there are no children to support the future.
00:18In Italy, every year there is a reduction in the number of children we have.
00:22In 2023, less than 400,000 children were born, 3.4% less than in 2022.
00:2925% less than 10 years ago.
00:33Is it an economic issue? It is an economic issue, but not only.
00:37There is a lack of education.
00:39We did a survey where 72% of young people in Europe know nothing about the ovarian reserve.
00:4962% are not aware of the treatment to help fertility.
00:55We have to face this level of education.
00:59Merck, as a company, is a leader in fertility.
01:03The treatment of fertility was born with Merck more than 50 years ago here in Italy.
01:08We need to share this education to face this problem that we have in Italy and throughout Europe.
01:15This is the first commitment we have.
01:17Second, we are a leader in the treatment of fertility.
01:2116% of people have a fertility problem.
01:26Health and fertility.
01:28A couple is two people.
01:3016% of each person has a health problem.
01:35For those who want to have children, it is a problem that we must address.
01:40Here at Merck, to guarantee our credibility,
01:44in June of this year, we launched the Fertility Benefit program.
01:50For all Merck employees worldwide,
01:54we support the treatment, the diagnosis,
01:58all the financial and psychological support for our employees who want to have children,
02:04to help in this process.
02:06I think this is the best example we can share with society.
02:10We want to help not only our employees, but all society in Italy.

Recommended